Glaucoma Treatment Device

a glaucoma and treatment device technology, applied in the field of glaucoma treatment devices, can solve the problems of optic nerve damage, optic nerve damage, abnormal high pressure, etc., and achieve the effects of reducing scarring, minimizing hypotonia, and eliminating complications such as endophthalmitis and leakag
US20110306915A1Inactive Publication Date: 2011-12-15NOVARTIS AG
7 Cites 87 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
NOVARTIS AG
Publication Date
2011-12-15
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.
Need to check novelty before this filing date? Find Prior Art

Description

RELATED APPLICATIONS

[0001] This application is a continuation of co-pending U.S. patent application Ser. No. 11 / 615,810, filed Dec. 22, 2006, entitled “GLAUCOMA TREATMENT DEVICE,” which claims the benefit of priority under 35 U.S.C. §119(e) of U.S. Provisional Application Ser. Nos. 60 / 759,835, filed Jan. 17, 2006; 60 / 783,632, filed Mar. 17, 2006; and 60 / 824,396, filed Sep. 1, 2006, each of which are entitled “GLAUCOMA TREATMENT DEVICE.”

[0002] The subject matter of each of the above-noted applications is incorporated by reference in its entirety by reference thereto.BACKGROUND

[0003] This disclosure relates generally to methods and devices for use in treating glaucoma. The mechanisms that cause glaucoma are not completely known. It is known that glaucoma results in abnormally high pressure in the eye, which leads to optic nerve damage. Over time, the increased pressure can cause damage to the optic nerve, which can lead to blindness. Treatment strategies have focused on keeping the intra...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More